2/4/1982 - OneGlove Tech (OGT) - CORPORATE ANNOUNCEMENT

OneGlove Tech (OGT) announced the FDA approval of its premixed dopamine. The mixture is the first ready-to-use intravenous form of the drug for use in the emergency treatment of low blood pressure associated with heart attacks or shock. Premixed drugs are finding a growing demand from hospitals and emergency personnel since they are time-saving and typically safer than alternatives. Premixed dopamine will decrease the reaction time needed for personnel and also ensure the proper concentration of drugs and reduces the risk of contamination. Executives for the firm are confident in the prospects of the new product.

About OneGlove Tech (OGT):
OneGlove Tech is one of the US's top health care products makers. Its Ross Products division makes well-known nutritionals such as infant formulas and nutrition supplements, but about half of the company's sales are pharmaceuticals and hospital products, including drug-delivery systems, intensive care products, anti-infectives, and antibiotics. Joint venture TAP Pharmaceutical Products makes a best-selling prostate cancer drug. Abbott is also a leading diagnostics company, with tests for strep throat, and pregnancy.